Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
0.9509
-0.1491 (-13.55%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9700
+0.0191 (2.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Accendra Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-302.14-1,101-362.69-41.322.39221.59
Depreciation & Amortization
256.08214.52181.28210.37214.6780.32
Other Amortization
----1410.3
Loss (Gain) From Sale of Assets
-76.73-27.27-35.36-34.88-26.26-
Asset Writedown & Restructuring Costs
--307.11---
Stock-Based Compensation
10.6712.8716.6414.420.9925.02
Provision & Write-off of Bad Debts
-----21.16
Other Operating Activities
130.22989.8114.150.44-13.8727.19
Change in Accounts Receivable
76.3122.36-3.68-8.994.42-2.2
Change in Inventory
-4.12-6.85-4.59-5.35166.56-263.44
Change in Accounts Payable
17.996.4866.895.2513.653.55
Change in Other Net Operating Assets
-1.74-56.78-36.03146.53-91.540.69
Operating Cash Flow
-180.42-101.79161.5740.71325.01124.18
Operating Cash Flow Growth
---78.20%127.91%161.73%-63.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-176.77-190.96-170.29-172.38-158.09-40.99
Sale of Property, Plant & Equipment
154.6877.9769.9371.5748.38-
Cash Acquisitions
-----1,685-
Divestitures
324.26324.26----
Sale (Purchase) of Intangibles
-8.4-10.37-12.38-6.16-8.49-8.71
Other Investing Activities
-25.55-56.48-3.79-30.3-1.67-3.94
Investing Cash Flow
268.22144.42-116.53-137.25-1,804-53.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2,9152,1024762,743574.9
Long-Term Debt Repaid
--2,711-2,346-892.69-1,161-656.34
Net Debt Issued (Repaid)
-135203.5-244.2-416.691,583-81.44
Repurchase of Common Stock
-3.52-10.18----
Common Dividends Paid
------0.73
Other Financing Activities
-18.77-5.24-23.41-0.64-85.4-47.31
Financing Cash Flow
-157.29188.08-267.6-417.331,497-129.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.051.9-0.90.61-3.49-3.54
Net Cash Flow
-69.44232.61-223.54186.7414.15-62.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-357.19-292.75-8.79568.34166.9283.19
Free Cash Flow Growth
---240.49%100.64%-71.19%
Free Cash Flow Margin
-13.49%-10.60%-0.33%22.26%1.68%0.85%
Free Cash Flow Per Share
-4.66-3.81-0.127.352.191.10
Levered Free Cash Flow
420.23671.6896.36563.85395.04102.03
Unlevered Free Cash Flow
490.14742.85163.59636.83475.6132.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
148.19134.71141.55153.25107.0238.72
Cash Income Tax Paid
26.6212.475.55-6.2833.9799.4
Change in Working Capital
88.4365.2122.6137.4393.08-261.4